The Royal Berkshire Hospital is a National Health Service hospital in the town of Reading in the English county of Berkshire. It provides acute hospital services to the residents of the western and central portions of Berkshire, and is managed by the Royal Berkshire NHS Foundation Trust.

During the past decade, Royal Berkshire Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 6 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 5 clinical trials were completed. i.e. 20.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Berkshire Hospital" #1 sponsor was "University of Oxford" with 12 trials, followed by "University College, London" with 4 trials sponsored, "University of Edinburgh" with 4 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Berkshire Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 4 trials as a collaborator, "NHS Lothian" with 4 trials as a collaborator, "Royal Berkshire NHS Foundation Trust" with 4 trials as a collaborator and "Lund University" with 3 trials as a collaborator. Other collaborators include 121 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Royal Berkshire Hospital" are "Atrial Fibrillation" (5 trials), "Breast Cancer" (4 trials), "Crohn Disease" (4 trials), "Multiple Myeloma" (3 trials) and "Out-of-hospital Cardiac Arrest" (3 trials). Many other conditions were trialed in "Royal Berkshire Hospital" in a lesser frequency.

Most popular intervention types in "Royal Berkshire Hospital" are "Drug" (36 trials), "Other" (17 trials), "Procedure" (12 trials), "Device" (10 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Edoxaban" (2 trials), "Empagliflozin" (2 trials), "Etrolizumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Berkshire Hospital" are 78 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Berkshire Hospital". undefined are not yet recruiting, 27 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Royal Berkshire Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Berkshire Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 24 trials that are defined as “Not Applicable".

Royal Berkshire Hospital has several departments that took part in Clinical trials: "Berkshire Cancer Centre at Royal Berkshire Hospital" - 20 trials